talactoferrin alfa: Clinical Trials

3 trials of talactoferrin alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Suspended 1, Unknown 1
Phase 11Unknown 1
Phase 31Suspended 1

Follow talactoferrin alfa: new trials by email Literature Review of talactoferrin alfa trials Research Report on talactoferrin alfa

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Talactoferrin alfa, Placebo - Severe Sepsis
Phase 2 / Phase 3SuspendedAgennix12802011-06-012012-02-03
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Talactoferrin, Placebo - Nosocomial Infections
Phase 1 / Phase 2UnknownAgennix1202009-06-012012-03-15
Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Talactoferrin alfa, Placebo - Severe Sepsis
Phase 2CompletedAgennix1902008-04-012011-08-23

Conditions studied

Sepsis (2)  ·  Cross Infection (1)

Sponsors

Agennix (3)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Israel (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Kalpalatha K Guntupalli, MD (1)

Results publications

PMID 23425819, PMID 26010687, PMID 27234409, PMID 27260839

NIH funding

R44HD057744 (1)